...

What Is Histopathology and How Does It Diagnose Disease at the Tissue Level?

The Examination That Provides the Most Definitive Answers in Medicine

In the hierarchy of diagnostic investigations, histopathology occupies a uniquely authoritative position. A blood test can suggest, an ultrasound can demonstrate, an MRI can characterise — but histopathology confirms. When a clinician needs to know with certainty whether a lump is cancer or a benign growth, whether a chronic disease is affecting specific organs, whether an infection is truly resolved, or what type of malignancy a tumour represents — the answer comes from histopathology. It is the investigation that provides the definitive tissue-level diagnosis upon which treatment decisions of the greatest consequence are based.

At Alnoor Diagnostic Centre in Shadman, Lahore, our histopathology laboratory provides the comprehensive tissue examination services that clinicians across the city depend on for accurate diagnosis, treatment planning, and patient management.


What Is Histopathology?

Histopathology is the microscopic examination of tissue samples to identify disease. The word derives from the Greek histos — meaning tissue — combined with pathology — the study of disease. It involves taking a piece of tissue from the body, processing it through a precise series of laboratory steps, staining it with dyes that highlight different cellular and structural components, and examining it under a microscope by a trained pathologist who interprets the cellular architecture and identifies any abnormalities present.

The fundamental principle underlying histopathology is that disease produces characteristic changes in the structure, cellular composition, and organisation of tissue that are visible at the microscopic level. A cancer disrupts the orderly cellular architecture of normal tissue, producing cells that are abnormally shaped, abnormally sized, dividing uncontrollably, and invading surrounding structures. An inflammatory condition fills tissue with immune cells responding to injury or infection. A degenerative disease produces characteristic patterns of cell death and fibrosis. The pathologist reads these microscopic patterns and translates them into a clinical diagnosis.


How Tissue Samples Are Obtained

Histopathology begins with the collection of tissue — and the method of collection depends on where the tissue is located, what clinical question is being asked, and how much tissue is needed for adequate examination.

Biopsy is the most common method — a small piece of tissue is removed from an abnormality identified clinically or on imaging. Core needle biopsies use a hollow needle to extract a cylindrical core of tissue from solid lesions — breast lumps, liver masses, prostate nodules, bone lesions, and lung masses are all routinely sampled this way. The sample is small but usually sufficient for histopathological diagnosis. Incisional biopsies remove a portion of a larger lesion for diagnosis before definitive treatment. Excisional biopsies remove the entire lesion — serving simultaneously as diagnostic and therapeutic.

Endoscopic biopsies are collected during gastroscopy, colonoscopy, bronchoscopy, or cystoscopy when abnormalities of the gastrointestinal, respiratory, or urological mucosa require tissue sampling. The gastroenterologist or pulmonologist collects the biopsy under direct endoscopic vision and the specimen is immediately placed in formalin for fixation before transport to the histopathology laboratory.

Surgical specimens represent the largest and most complex tissue samples received by histopathology laboratories — resected tumours, removed organs, amputated limbs, and placental tissue all require comprehensive pathological examination to characterise the disease, confirm complete removal, assess margins, and provide prognostic information.


The Laboratory Processing Journey — From Tissue to Slide

What happens in the histopathology laboratory between the arrival of a tissue sample and the pathologist’s report involves a remarkable series of precise, standardised steps that have been refined over more than a century of pathological practice.

Fixation — Immediately upon collection, tissue is placed in formalin solution. Formalin penetrates the tissue and chemically cross-links proteins, halting all biological processes and preserving the cellular architecture in the state it was at the moment of collection. Adequate fixation is essential — inadequately fixed tissue undergoes autolysis, destroying the microscopic detail that the pathologist needs to interpret. Fixation typically requires six to twenty-four hours depending on tissue size.

Grossing — A pathologist or trained pathology assistant examines the fixed specimen macroscopically — with the naked eye — before any tissue is processed. This gross examination identifies the size, shape, colour, and consistency of the specimen and any visible abnormalities. Appropriate sections are selected for microscopic examination, margins are inked to allow assessment of completeness of excision, and representative sections from different areas of the specimen are taken. This gross examination is itself diagnostically informative and is documented in detail in the pathology report.

Tissue processing — Selected tissue sections are placed in cassettes and passed through an automated tissue processor. The processing sequence dehydrates the tissue through a series of graded alcohols, clears the alcohol with xylene, and infiltrates the tissue with molten paraffin wax. This process typically runs overnight and produces tissue permeated with wax that provides a firm supporting matrix.

Embedding — Wax-infiltrated tissue is embedded in paraffin blocks — each tissue section is carefully oriented within a mould, molten wax is poured around it, and the block is cooled until solid. The resulting paraffin block contains the tissue section supported in a rigid wax matrix that allows extremely thin sections to be cut without the tissue crumbling or distorting.

Sectioning — Paraffin blocks are mounted on a precision instrument called a microtome. Its blade cuts sections of tissue at a thickness of three to five micrometres — a fraction of a human hair’s width. These gossamer-thin sections are floated onto warm water, picked up on glass slides, and dried in an oven to adhere firmly to the slide surface.

Staining — Unstained tissue sections are colourless and almost invisible under the microscope. Staining makes tissue components visible by binding different coloured dyes to different cellular structures. The universal standard stain in histopathology is haematoxylin and eosin — H&E. Haematoxylin stains cell nuclei blue-purple. Eosin stains cytoplasm and extracellular material pink. The resulting slide shows the tissue’s cellular architecture in vivid contrast that the pathologist can read and interpret.

Special stains beyond H&E are applied when specific structures need to be highlighted. Periodic acid-Schiff stain identifies glycogen and fungi. Ziehl-Neelsen stain identifies mycobacteria — the organisms causing tuberculosis. Masson’s trichrome stain highlights collagen and fibrosis in liver and kidney biopsies. Congo red stain identifies amyloid deposits. Each special stain answers a specific diagnostic question that H&E alone cannot address.

Immunohistochemistry — One of the most powerful advances in histopathology over the past three decades is immunohistochemistry — the application of antibodies to tissue sections that bind specifically to particular proteins within cells. By applying an antibody against a specific protein — a tumour marker, a viral antigen, a cellular differentiation marker — and then applying a detection system that produces a coloured reaction wherever the antibody has bound, the pathologist can determine which proteins are expressed within the tissue cells.

Immunohistochemistry is essential for tumour classification. It determines the tissue of origin of a metastatic tumour whose primary site is unknown. It distinguishes between lymphoma subtypes — each requiring different treatment. It identifies hormone receptor status in breast cancer — oestrogen and progesterone receptors — and HER2 overexpression, both of which determine eligibility for targeted therapies. It identifies specific viral infections within tissue — HPV in cervical lesions, EBV in certain lymphomas. Modern cancer treatment depends on immunohistochemical tumour profiling to match therapy to tumour biology.


What the Pathologist Looks for and Reports

The pathologist examining a stained tissue section reads the microscopic landscape — assessing the architectural organisation of tissue, the characteristics of individual cells, the nature of any inflammatory infiltrate, the presence and pattern of any malignancy, and the relationship between abnormal and normal tissue.

For a malignant tumour, the pathology report provides the diagnosis — the tumour type and subtype — the grade reflecting how aggressive the cancer cells appear microscopically, the stage-relevant measurements including tumour size and depth of invasion, the lymphovascular invasion status, the resection margin status confirming whether the tumour was completely removed or whether malignant cells are present at the surgical margin, and the results of any immunohistochemical studies performed. This information is the complete biological profile of the tumour that the treating oncologist uses to select appropriate systemic therapy, plan radiation, and estimate prognosis.

For non-malignant conditions, the report describes the specific pathological changes identified — the pattern of inflammation in an inflammatory bowel disease biopsy, the degree of fibrosis in a liver biopsy from a hepatitis patient, the presence of Helicobacter pylori in a gastric biopsy, the characteristics of a skin rash at the cellular level, or the nature of an infectious organism identified in tissue.


The Turnaround Time for Histopathology Reports

Standard histopathology processing and reporting typically requires five to seven working days from receipt of the specimen — because each step in the processing and staining sequence has its own time requirement that cannot be safely rushed without compromising tissue quality. When clinical urgency demands faster reporting — in a patient awaiting cancer surgery whose management depends on the biopsy result — expedited processing can reduce turnaround to two to three days.

Intraoperative frozen section examination — where tissue is rapidly frozen rather than paraffin-embedded, allowing preliminary examination within fifteen to twenty minutes during an ongoing surgical procedure — allows the surgeon to receive a preliminary diagnosis before closing. This technique is used when the surgical approach depends on whether a lesion is malignant or benign, or when margin assessment during surgery is critical.


Histopathology at Alnoor Diagnostic Centre, Lahore

At Alnoor Diagnostic Centre in Shadman, Lahore, our histopathology laboratory provides the complete tissue processing, staining, immunohistochemistry, and expert pathological reporting services that clinicians across the city depend on. Our experienced pathologists examine every specimen with the thoroughness and clinical relevance that accurate diagnosis demands — ensuring that every patient receives the definitive tissue-level answer their clinical situation requires.

Leave a Reply